Format

Send to

Choose Destination
Circ J. 2008 May;72(5):850-2.

Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm.

Author information

1
Department of Pediatrics, Kochi National Hospital, Kochi, Japan.

Erratum in

  • Circ J. 2008 Jul;72(7):1212.

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is considered to be 1 of the factors that induce vasculitis, including coronary artery aneurysm (CA), in Kawasaki disease (KD), because the blood concentration of TNF-alpha is higher in patients with CA compared with those without. Therefore, an anti-TNF-alphaagent (infliximab) was administered to a 1-month-old girl with refractory KD complicated by CA and subsequently, the CA improved and KD was controlled without complications 20 months after the onset.

PMID:
18441471
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for J-STAGE, Japan Science and Technology Information Aggregator, Electronic
Loading ...
Support Center